≡ Risteys
FG R12 + FR

Documentation Changelog GitHub Contact & Feedback

Malignant neoplasm of testis, excluding all cancers (controls excluding all cancers)

Endpoint Browser PheWeb

C3_TESTIS_EXALLC

Endpoint definition

↥

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

only males

226837

2. Check conditions

None

226837

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — C62
  • Hospital discharge: ICD-9 — 186
  • Hospital discharge: ICD-8 — 186
  • Cause of death: ICD-10 — C62
  • Cause of death: ICD-9 — 186
  • Cause of death: ICD-8 — 186
  • Cancer registry: Topography ICD-O-3 — C62
  • Cancer registry: Morphology ICD-O-3 — ANY
  • Cancer registry: Behaviour codes — 3

3 out of 7 registries used, show all original rules.

720

4. Check minimum number of events

None

720

5. Include endpoints

None

720

6. Filter based on genotype QC (FinnGen only)

720

Control definitions (FinnGen only)

Control exclude
C3_CANCER, C3_CANCER_WIDE_EXALLC

Extra metadata

First used in FinnGen datafreeze
DF12

Similar endpoints

↥

List of similar endpoints to Malignant neoplasm of testis, excluding all cancers (controls excluding all cancers) based on the number of shared cases.

Venn diagram with an highlighted set fully inside another set Similar with more cases:

Venn diagram with a set fully inside an highlighted set Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded (different definition than used in FinnGen).

-FinnGen-

Key figures

All Female Male
Number of individuals 720 - 720
Unadjusted period prevalence (%) 0.32 - 0.32
Median age at first event (years) 37.17 - 37.17

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
566
Matched controls
5659
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
D40.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Testis
725.5
323.0
333
11
KFC00
NOMESCO Finland
Unilateral orchiectomy
1256.7
323.0
404
11
C62.11
ICD-10 Finland
Malignant tumor of the descending testicle, seminoma
+∞
268.8
236
*
9061/3-C62.9
ICD-O-3
Seminoma, NOS, of testis, NOS
+∞
245.1
217
*
130
Kela drug reimbursment
Malignant tumour
+∞
197.8
178
*
JN4BD
NOMESCO Finland
Extensive body CT
36.8
176.3
231
104
C62.12
ICD-10 Finland
Malignant tumor of the descending testicle, embryonic carsinoma, teratocarcinoma or coriocarsinoma
+∞
160.2
146
*
A03FA01
ATC
metoclopramide; systemic, rectal
17.6
130.1
220
197
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
1298.2
112.5
106
*
C62.10
ICD-10 Finland
Malignant tumor of the descending testicle, no histological verification
+∞
98.9
92
*
KF8AE
NOMESCO Finland
Ultrasound examination of scrotum
18.6
98.3
158
115
A04AA02
ATC
granisetron; systemic, transdermal
+∞
88.9
83
*
C62.19
ICD-10 Finland
Malignant tumor of the descending testicle, other or undetermined histology
+∞
88.9
83
*
JN4AD
NOMESCO Finland
Body CT examination
22.6
84.2
125
70
KFH50
NOMESCO Finland
Insertion of prosthetic replacement for testis
282.9
74.3
74
*
9085/3-C62.9
ICD-O-3
Mixed germ cell tumor of testis, NOS
+∞
73.5
69
*
C62.1
ICD-10 Finland
Malignant neoplasm: Descended testis
+∞
70.3
66
*
H02AB02
ATC
dexamethasone; systemic
58.8
69.4
81
16
L03AA02
ATC
filgrastim; parenteral
252.5
66.7
67
*
GD1AA
NOMESCO Finland
Thorax X-ray examination
4.6
63.3
334
1344
9061/3-C62.1
ICD-O-3
Seminoma, NOS, of descended testis
+∞
62.7
59
*
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
+∞
60.5
57
*
7511
FHL
Orchidectomy (unilateral), also includes funicularectomy
629.5
58.8
57
*
C62.99
ICD-10 Finland
Malignant tumor in unspecified location in testis,other or undetermined histology
+∞
54.0
51
*
C62.90
ICD-10 Finland
Malignant tumor in unspecified location in testis, no histological verification
532.2
50.2
49
*
A04AA01
ATC
ondansetron; systemic, rectal
35.9
49.8
64
20
18699
ICD-8 Finland
Malignant neoplasm of testis
+∞
49.7
47
*
9070/3-C62.9
ICD-O-3
Embryonal carcinoma, NOS, of testis, NOS
+∞
48.6
46
*
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
4.1
47.8
242
866
C83.31
ICD-10 Finland
Diffuse lymphoma with large B cells
+∞
39.0
37
*
JN3AD
NOMESCO Finland
Abdominal CT examination
7.5
38.4
96
150
JN3BD
NOMESCO Finland
Extensive abdominal CT
6.2
38.3
111
213
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
+∞
37.9
36
*
C62.91
ICD-10 Finland
Malignant tumor in unspecified location in testis, seminoma
+∞
37.9
36
*
121
Kela drug reimbursment
Severe hypofunction of sexual glands
30.3
37.5
50
18
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
+∞
36.9
35
*
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
104.5
36.2
39
*
C62.00
ICD-10 Finland
Malignant tumor of the non-descending testicle, no histological verification
+∞
35.8
34
*
L03AA13
ATC
pegfilgrastim; parenteral
+∞
35.8
34
*
C62.92
ICD-10 Finland
Malignant tumor in unspecified location in testis, embryonic carsinoma, teratocarcinoma or coriocarsinoma
+∞
35.8
34
*
PJD53
NOMESCO Finland
Block dissection of aortic lymph nodes
+∞
33.7
32
*
C62.01
ICD-10 Finland
Malignant tumor of the non-descending testicle, seminoma
+∞
33.7
32
*
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
+∞
33.7
32
*
9680/3-C62.9
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of testis, NOS
+∞
32.6
31
*
C61
ICD-10 Finland
Malignant neoplasm of prostate
341.7
32.2
32
*
XZZ00
NOMESCO Finland
Active surveillance of a diagnosed cancer
+∞
31.5
30
*
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
330.0
31.1
31
*
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
23.8
29.6
42
19
C62.02
ICD-10 Finland
Malignant tumor of the non-descending testicle, embryonic carsinoma, teratocarcinoma or coriocarsinoma
+∞
29.4
28
*
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
+∞
29.4
28
*
WX408
NOMESCO Finland
General anesthesy, balanced
3.3
29.4
181
704
D70.82
ICD-10 Finland
Drug-induced neutropenia
51.5
28.7
34
7
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
+∞
28.4
27
*
C77.2
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Intra-abdominal lymph nodes
+∞
28.4
27
*
WF049
NOMESCO Finland
Radiotherapy of metastasis
+∞
27.3
26
*
9085/3-C62.1
ICD-O-3
Mixed germ cell tumor of descended testis
+∞
26.2
25
*
WF002
NOMESCO Finland
Radical radiotherapy
260.9
24.9
25
*
C62.9
ICD-10 Finland
Malignant neoplasm: Testis, unspecified
+∞
24.1
23
*
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
4.0
24.1
106
309
9081/3-C62.9
ICD-O-3
Teratocarcinoma of testis, NOS
+∞
23.1
22
*
C62
ICD-10 Finland
Malignant neoplasm of testis
+∞
23.1
22
*
JN4CD
NOMESCO Finland
Very extensive body CT
20.4
21.0
31
16
1869A
ICD-9 Finland
Malignant neoplasm of testis, Other and unspecified testis[NEOPL MAL TESTIS (SCROTALIS),SEMINOMA]
+∞
21.0
20
*
C78.0
ICD-10 Finland
Secondary malignant neoplasm of lung
+∞
21.0
20
*
G03BA03
ATC
testosterone; systemic, rectal, sublingual, transdermal
3.9
20.5
91
266
N02BE01
ATC
paracetamol; systemic, rectal
2.6
20.3
459
3502
N02AA05
ATC
oxycodone; systemic
4.2
19.7
80
215
WD135
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
206.8
19.7
20
*
D29.2
ICD-10 Finland
Benign neoplasm: Testis
47.8
19.3
23
5
WZC30
NOMESCO Finland
Teaching
3.8
18.1
80
232
N45.9
ICD-10 Finland
Orchitis, epididymitis and epididymo-orchitis without abscess
5.9
17.8
51
94
Y78
ICPC
Malign neopl male genital other
+∞
17.8
17
*
YL1BD
NOMESCO Finland
Extensive CT examination of pelvis for dose design of radiotherapy
+∞
17.8
17
*
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
+∞
17.8
17
*
XX3DW
NOMESCO Finland
Time consuming IT work
5.6
17.8
53
103
WX320
NOMESCO Finland
Spinalanesthesy
2.8
17.7
128
531
A49.9
ICD-10 Finland
Bacterial infection, unspecified
4.1
17.5
72
196
L01BC06
ATC
capecitabine; oral
+∞
16.7
16
*
9080/3-C62.9
ICD-O-3
Teratoma, malignant, NOS, of testis, NOS
+∞
16.7
16
*
WW500
NOMESCO Finland
Blood transfusion
12.1
16.7
30
26
WX402
NOMESCO Finland
General anaesthesia
3.1
16.3
100
371
DFF00
NOMESCO Finland
Pure tone audiometry
4.1
16.1
65
174
1869B
ICD-9 Finland
Malignant neoplasm of testis, Other and unspecified testis[NEOPL MAL TESTIS (SCROT),CA EMBR/TERATOCA/CHORIOCA]
+∞
15.7
15
*
L03AA14
ATC
lipegfilgrastim; parenteral
+∞
15.7
15
*
WF003
NOMESCO Finland
Adjuvant radiotherapy
164.2
15.5
16
*
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
6.9
14.9
37
57
Y05
ICPC
Scrotum/testis sympt/compl other
10.1
14.9
29
30
E29.1
ICD-10 Finland
Testicular hypofunction
6.5
14.7
38
62
WD415
NOMESCO Finland
Demanding antibody therapy of methastized malignancy
+∞
14.6
14
*
Z08.7
ICD-10 Finland
Follow-up examination after combined treatment for malignant neoplasm
+∞
14.6
14
*
WX302
NOMESCO Finland
Thoracal epidural anesthesy
7.2
14.1
34
50
ZX090
NOMESCO Finland
Other technic of radiotherapy
+∞
13.6
13
*
C78.6
ICD-10 Finland
Secondary malignant neoplasm of retroperitoneum and peritoneum
+∞
13.6
13
*
116
Kela drug reimbursment
Prostate cancer
+∞
13.6
13
*
A04AD12
ATC
aprepitant; systemic
+∞
13.6
13
*
ZX120
NOMESCO Finland
Intravenous
3.7
13.1
58
168
B01AB10
ATC
tinzaparin; parenteral
5.5
13.0
38
73
Z51.5
ICD-10 Finland
Palliative care
11.9
12.9
23
20
JN4JR
NOMESCO Finland
Whole body extensive metabolic PET with CT
51.2
12.9
15
*
B01AB05
ATC
enoxaparin; parenteral
2.3
12.8
133
661
Z85.4
ICD-10 Finland
Personal history of malignant neoplasm of genital organs
+∞
12.5
12
*
C20.91
ICD-10 Finland
Malignant tumor of the rectum invasive carcinoma
+∞
12.5
12
*
WF004
NOMESCO Finland
Palliative radiotherapy
+∞
12.5
12
*
E89.5
ICD-10 Finland
Postprocedural testicular hypofunction
132.7
12.5
13
*
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
4.2
12.1
46
117
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
47.7
11.9
14
*
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
66.3
11.6
13
*
A02BC02
ATC
pantoprazole; systemic
1.9
11.6
300
2136
ZX070
NOMESCO Finland
Intensity modified radiotherapy
+∞
11.5
11
*
YL1AD
NOMESCO Finland
CT examination of pelvis for dose design of radiotherapy
+∞
11.5
11
*
1869X
ICD-9 Finland
Malignant neoplasm of testis, Other and unspecified testis[NEOPL MAL TESTIS (SCROTALIS),EI HIST VAHV]
+∞
11.5
11
*
C83.3
ICD-10 Finland
Diffuse large B-cell lymphoma
+∞
11.5
11
*
5703
FHL
Removal of lymph nodes from the retroperitoneal space
+∞
11.5
11
*
C85.9
ICD-10 Finland
Non-Hodgkin lymphoma, unspecified
+∞
11.5
11
*
R50.9
ICD-10 Finland
Fever, unspecified
2.7
11.4
86
358
WX404
NOMESCO Finland
Intravenous generell anesthesy
2.5
11.3
94
415
KF8AE
SPAT
NA
9.5
11.1
22
24
JN6BD
NOMESCO Finland
Extensive CT of torso and neck
44.2
11.0
13
*
KFA00
NOMESCO Finland
Exploration of testis
10.9
10.8
20
19
Z01.1
ICD-10 Finland
Examination of ears and hearing
2.6
10.5
79
331
C62.0
ICD-10 Finland
Malignant neoplasm: Undescended testis
+∞
10.4
10
*
9591/3-C62.9
ICD-O-3
Malignant lymphoma, non-Hodgkin, NOS, of testis, NOS
+∞
10.4
10
*
C62.09
ICD-10 Finland
Malignant tumor of the non-descending testicle, other or undetermined histology
+∞
10.4
10
*
A04AA55
ATC
palonosetron, combinations; systemic
+∞
10.4
10
*
C25.0
ICD-10 Finland
Malignant neoplasm: Head of pancreas
+∞
10.4
10
*
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
6.9
10.0
24
36
JA1AE
NOMESCO Finland
Ultrasound examination of groin and abdominal wall
9.0
9.8
20
23
N05BA06
ATC
lorazepam; systemic, sublingual
3.9
9.5
38
102
JN6AD
NOMESCO Finland
CT of torso and neck
30.6
9.4
12
*
WD305
NOMESCO Finland
Simple therapy of methastized malignancy with biomodifiers
+∞
9.4
9
*
9070/3-C62.1
ICD-O-3
Embryonal carcinoma, NOS, of descended testis
+∞
9.4
9
*
8090/3-C44.3
ICD-O-3
Basal cell carcinoma, NOS, of skin of other and unspecified parts of face
+∞
9.4
9
*
XW000
NOMESCO Finland
Bone marrow biopsy
6.1
9.1
24
41
TPH04
NOMESCO Finland
Cathetrisation of vein
2.1
8.9
105
546
TPX10
NOMESCO Finland
Implantation of vascular injection port
6.5
8.9
22
35
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
6.5
8.9
22
35
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
50.8
8.7
10
*
2395A
ICD-9 Finland
Neoplasm of unspecified nature, Other genito-urinary organs
50.8
8.7
10
*
N50.9
ICD-10 Finland
Disorder of male genital organs, unspecified
11.8
8.6
15
13
KBV02
NOMESCO Finland
Cystoscopic insertion of stent into ureter
6.9
8.4
20
30
N46
ICD-10 Finland
Male infertility
3.7
8.4
36
103
L02BB03
ATC
bicalutamide; oral
+∞
8.3
8
*
9063/3-C62.9
ICD-O-3
Spermatocytic seminoma of testis, NOS
+∞
8.3
8
*
L02AE02
ATC
leuprorelin; implant, parenteral
+∞
8.3
8
*
8140/3-C20.9
ICD-O-3
Adenocarcinoma, NOS, of rectum, NOS
+∞
8.3
8
*
N02AX02
ATC
tramadol; systemic, rectal
1.7
8.2
198
1332
7513
FHL
Test prosthesis installation
17.5
8.1
12
7
N50.8
ICD-10 Finland
Other specified disorders of male genital organs
7.9
7.9
17
22
ZXA05
NOMESCO Finland
Left side
1.9
7.6
111
631
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
2.1
7.5
84
427
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
3.8
7.5
30
82
C67.9
ICD-10 Finland
Malignant neoplasm: Bladder, unspecified
81.1
7.4
8
*
KA1FN
NOMESCO Finland
Isotope renography
13.6
7.4
12
9
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
3.2
7.3
36
116
JN4ED
NOMESCO Finland
Body CT examination with specail preparation
+∞
7.3
7
*
C83.39
ICD-10 Finland
Diffuse non-Hodgkin's large cell lymphoma UNS
+∞
7.3
7
*
9071/3-C62.9
ICD-O-3
Yolk sac tumor, NOS, of testis, NOS
+∞
7.3
7
*
JN4DG
NOMESCO Finland
Body very extensive MRI with high intensity magnet
+∞
7.3
7
*
YJ1AD
NOMESCO Finland
CT examination of abdomen for dose design of radiotherapy
+∞
7.3
7
*
C79.5
ICD-10 Finland
Secondary malignant neoplasm of bone and bone marrow
+∞
7.3
7
*
1860B
ICD-9 Finland
Malignant neoplasm of testis, Undescended testis[NEOP MAL TEST (ABD/ING),CA EMBR/TERATOCA/CHORIOCA]
+∞
7.3
7
*
C64.88
ICD-10 Finland
Other malignant neoplasm of kidney, except renal pelvis
+∞
7.3
7
*
KFB00
NOMESCO Finland
Biopsy of testis
16.0
7.2
11
7
M04AA01
ATC
allopurinol; systemic
2.3
7.2
69
328
J01MA12
ATC
levofloxacin; systemic
2.1
7.1
84
438
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
8.9
7.1
14
16
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
3.4
6.9
31
94
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.1
6.7
81
425
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
2.5
6.6
50
212
KFD43
NOMESCO Finland
Unilateral vasectomy or ligature of vas deferens
70.6
6.4
7
*
PJD45
NOMESCO Finland
Excision of inguinal lymph nodes
70.6
6.4
7
*
JN2CG
NOMESCO Finland
Extensive MRI examination of lower part of abdoment with high intensity magnet
14.5
6.4
10
7
Y28
ICPC
Limited function/disability (Y)
9.4
6.3
12
13
ZX080
NOMESCO Finland
Image guided radiotherapy
+∞
6.3
6
*
C67.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of bladder
+∞
6.3
6
*
YG1BD
NOMESCO Finland
Extensive CT examination of thorax for dose design of radiotherapy
+∞
6.3
6
*
KFC10
NOMESCO Finland
Bilateral orchiectomy
+∞
6.3
6
*
C77.9
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Lymph node, unspecified
+∞
6.3
6
*
XX9CD
NOMESCO Finland
Very extensive complementary CT
+∞
6.3
6
*
C85.1
ICD-10 Finland
B-cell lymphoma, unspecified
+∞
6.3
6
*
KKB10
NOMESCO Finland
Excision of retroperitoneal tumour
+∞
6.3
6
*
C25.9
ICD-10 Finland
Malignant neoplasm: Pancreas, unspecified
+∞
6.3
6
*
KFC96
NOMESCO Finland
Other total excision of testis or epididymis
+∞
6.3
6
*
8120/3-C67.9
ICD-O-3
Transitional cell carcinoma, NOS, of bladder, NOS
+∞
6.3
6
*
PJ2AT
NOMESCO Finland
Biopsy of lymphnode with ultrasound guidance
27.0
6.2
8
*
R59.9
ICD-10 Finland
Enlarged lymph nodes, unspecified
10.2
6.0
11
11
AA1BD
NOMESCO Finland
Extensive CT of head and brain
5.6
6.0
16
29
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
2.0
6.0
79
427

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
177
14
167.31
307.65
10.2
1.3
—
—
—
0
0
(4035726)
181
150
15.78
188.98
1.2
1.3
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
151
91
20.73
186.49
3.2
1.5
iu/l
15.9
6.8
6.49
122
72
(3009214) Lutropin [Units/volume] in Serum or Plasma
196
224
11.65
165.03
2.9
1.6
u/l
7.4
4.1
7.14
165
188
(3017446) Testosterone [Moles/volume] in Serum or Plasma
297
873
5.09
96.68
4.1
2.4
nmol/l
13.4
15.3
4.40
283
800
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
481
2284
4.33
78.03
10.3
4.5
umol/l
10.7
13.3
6.13
476
2169
(3021879) Hepatitis B virus core Ab [Presence] in Serum
188
525
4.49
62.27
1.3
1.6
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
298
1292
3.23
49.65
2.1
1.6
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
578
3692
3.87
49.13
12.6
5.9
u/l
78.7
75.1
0.93
568
3473
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
213
788
3.42
45.61
1.6
1.6
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
468
2746
3.01
43.53
13.2
8.3
e9/l
3.6
4.2
6.83
427
2399
(3017143) Hepatitis C virus Ab [Presence] in Serum
212
805
3.32
43.25
1.7
1.8
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
276
1246
2.97
41.42
5.3
2.0
mmol/l
2.4
2.4
0.60
248
1073
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
47
9
55.71
40.01
8.1
2.7
—
—
—
0
0
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
69
133
5.63
34.75
1.7
3.1
%
169.7
187.2
0.80
69
128
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
170
646
3.14
33.80
5.7
2.0
mmol/l
2.4
2.4
1.11
151
549
(3002582) Erythrocytes [#/volume] in Urine
264
1297
2.63
32.17
3.5
2.8
e6/l
56.9
105.1
0.34
207
1003
(42870588) Differential panel, method unspecified - Blood
304
1614
2.53
31.32
5.8
6.3
—
—
—
0
0
(3002256) Pathology report gross observation
115
365
3.56
30.43
1.3
1.1
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
243
1173
2.62
30.41
3.3
2.8
e6/l
0.4
0.3
0.21
190
874
(3031040) Bacteria [#/volume] in Urine by Automated count
418
2590
2.46
30.39
4.1
3.1
e6/l
4.2
314.7
—
5
38
(36304419) Bacteria [Presence] in Urine
237
1143
2.60
29.59
3.2
2.7
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
325
1826
2.42
29.04
4.5
3.7
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
236
1157
2.55
28.27
1.9
2.0
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
328
1869
2.39
28.17
9.4
4.5
g/l
36.2
36.8
0.79
306
1727
(3018095) Leukocytes [#/volume] in Urine
279
1480
2.45
28.15
3.9
3.2
e6/l
71.2
84.2
0.13
214
1069
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
288
1576
2.38
26.83
3.6
2.9
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
239
1220
2.44
25.87
1.4
1.3
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
72
185
4.21
25.61
5.5
2.0
ug/l
4.2
4.2
0.00
57
147
(3013826) Glucose [Moles/volume] in Serum or Plasma
425
2801
2.26
24.79
6.0
4.8
mmol/l
6.6
6.8
0.80
409
2649
(3021589) Normoblasts [#/volume] in Blood
352
2165
2.22
24.15
10.9
8.5
e9/l
0.0
0.0
0.06
289
1772
(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen
46
85
5.71
24.13
3.2
6.3
—
—
—
0
0
(40761995) Spermatozoa Progressive [#/volume] in Semen
46
85
5.71
24.13
1.6
3.2
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
343
2099
2.21
23.70
10.5
6.2
mmol/l
1.2
1.2
0.51
270
1789
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
156
680
2.65
23.32
3.2
2.7
e6/l
0.4
0.6
0.50
96
367
(3019069) Monocytes/100 leukocytes in Blood
364
2310
2.16
22.61
6.6
6.8
%
9.0
9.0
0.13
352
2185
(3006504) Eosinophils/100 leukocytes in Blood
362
2293
2.16
22.59
6.3
6.5
%
2.7
3.1
2.71
351
2163
(3022096) Basophils/100 leukocytes in Blood
355
2234
2.16
22.50
6.3
6.6
%
0.7
0.7
0.26
342
2119
(3002030) Lymphocytes/100 leukocytes in Blood
373
2399
2.15
22.27
6.4
6.4
%
26.9
28.4
1.79
359
2264
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
158
717
2.54
21.60
3.0
2.5
e6/l
0.9
0.9
0.08
98
405
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
310
1886
2.13
21.07
9.0
5.8
mmol/l
1.2
1.2
0.45
299
1706
(3026782) Osmolality of Urine
172
833
2.40
20.31
2.8
2.3
mosm/kgh2o
593.4
586.4
0.14
152
694
(3044640) Blood type and Crossmatch panel - Blood
226
1229
2.22
20.30
3.2
2.3
—
—
—
0
0
(40758558) Short blood count panel - Blood
211
1131
2.22
19.53
11.6
6.0
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
431
3018
2.07
19.53
4.0
3.3
—
—
—
0
0
(3001604) Monocytes [#/volume] in Blood
370
2454
2.04
19.46
6.1
6.4
e9/l
0.6
0.6
0.56
315
2148
(3006315) Basophils [#/volume] in Blood
370
2460
2.04
19.26
6.1
6.4
e9/l
0.0
0.0
1.99
316
2162
(3019198) Lymphocytes [#/volume] in Blood
379
2542
2.04
19.25
6.2
6.5
e9/l
1.6
1.9
8.03
330
2253
(3033658) Prothrombin time (PT) actual/Normal
215
1172
2.19
19.01
5.4
4.0
%
91.8
86.3
2.72
210
1149
(3023368) Bacteria identified in Blood by Culture
228
1273
2.16
18.96
6.6
4.1
—
—
—
0
0
(3018010) Neutrophils/100 leukocytes in Blood
359
2372
2.02
18.90
6.1
6.3
%
57.7
56.4
1.23
346
2250
(3013115) Eosinophils [#/volume] in Blood
374
2532
1.99
18.12
6.5
6.8
e9/l
0.2
0.2
4.76
325
2248
(3032080) INR in Blood by Coagulation assay
290
1805
2.02
17.78
10.9
9.6
inr
1.3
1.3
0.34
84
532
(3026493) Urate [Moles/volume] in Serum or Plasma
223
1290
2.06
16.52
3.5
2.4
umol/l
6807.2
6635.5
0.01
207
1157
(3000850) Epithelial cells [#/volume] in Urine
167
867
2.21
16.39
2.8
2.3
e6/l
3.2
2.6
0.40
147
751
(40768795) Lymph node Pathology biopsy report
16
14
11.67
15.36
1.1
1.0
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
177
987
2.05
14.22
1.8
1.8
mg/l
1.3
1.0
0.85
135
703
(3018418) pH of Serum or Plasma
201
1177
1.98
14.06
6.7
3.4
ph
7.4
7.4
0.55
70
206
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
599
5003
2.17
13.75
20.4
9.9
ml/min/173m2
89.5
88.4
0.48
537
4071
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
17
5
34.76
13.55
1.2
1.0
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
31
68
4.72
13.41
1.9
1.8
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
166
941
1.99
12.58
2.9
2.3
—
—
—
0
0
(3017115) Methotrexate [Moles/volume] in Serum or Plasma
12
0
+∞
12.53
6.3
0.0
umol/l
0.4
—
—
12
0
(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma
16
19
8.59
12.41
3.5
1.1
u/l
187.6
194.8
0.15
16
19
(3019550) Sodium [Moles/volume] in Serum or Plasma
620
5321
2.19
12.12
22.7
13.1
mmol/l
139.4
139.7
2.91
609
5165
(3023103) Potassium [Moles/volume] in Serum or Plasma
620
5346
2.15
11.57
23.2
13.2
mmol/l
4.0
4.0
0.67
608
5186
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
35
96
3.78
11.36
2.0
1.7
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
41
126
3.39
11.25
3.7
2.9
u/ml
0.3
0.3
0.32
21
66
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
35
99
3.66
10.87
2.0
1.7
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
129
707
2.00
10.62
2.5
1.8
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
91
445
2.20
10.10
3.9
2.9
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
613
5345
1.99
9.85
21.1
11.2
mg/l
23.8
24.9
0.36
518
4074
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
31
87
3.68
9.75
2.7
4.1
%
58.3
56.3
0.51
31
87
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
36
112
3.33
9.70
7.3
5.7
iu/ml
861.5
608.4
—
6
14
(4038314)
12
14
8.70
9.37
1.2
1.3
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
30
85
3.64
9.31
2.7
4.0
e9/l
4.0
4.3
0.26
30
85
(40768800) Prostate Pathology biopsy report
18
38
4.83
8.15
1.3
1.1
—
—
—
0
0
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
27
79
3.51
8.01
2.6
3.0
—
478.1
—
0
9
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
64
301
2.24
7.80
2.2
1.6
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
523
4471
1.62
7.54
27.2
13.6
%
13.5
13.4
2.14
515
4356
(3022948) Iron [Moles/volume] in Serum or Plasma
115
677
1.83
7.51
3.4
2.4
umol/l
12.7
14.4
1.56
107
622
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
92
509
1.93
7.28
2.5
1.7
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
15
30
5.09
7.21
1.3
1.2
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
10
13
7.79
7.13
2.3
1.2
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
10
13
7.79
7.13
2.3
1.2
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
10
13
7.79
7.13
2.3
1.2
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
80
425
1.99
7.11
1.9
2.0
—
—
—
0
0
(3019225) pH of Specimen
74
384
2.03
7.02
5.4
3.6
—
—
—
0
0
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
16
35
4.65
6.96
2.0
1.7
nmol/l
0.1
0.1
0.11
16
27
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
19
48
4.04
6.93
1.7
2.1
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
283
2143
1.53
6.83
3.1
2.9
estimate
0.0
0.0
0.49
72
359
(3021601) Nitrite [Presence] in Urine by Test strip
281
2133
1.52
6.66
4.6
4.0
estimate
0.0
0.0
0.00
73
378
(40761536) Microorganisms panel - Urine sediment
68
351
2.04
6.55
3.4
3.1
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
178
1227
1.60
6.45
3.2
2.5
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
117
724
1.74
6.42
2.9
2.5
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
57
279
2.13
6.32
1.6
1.4
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
98
579
1.80
6.30
3.8
2.4
%
23.6
25.8
0.91
85
498
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
17
43
4.02
6.19
2.1
1.6
—
—
—
0
0
(3004789) Transferrin [Mass/volume] in Serum or Plasma
103
622
1.77
6.15
3.6
2.4
g/l
2.2
2.3
0.21
97
571
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
639
5848
1.82
6.13
14.9
8.2
u/l
32.0
33.6
1.26
634
5656
(3000991) Gas panel - Venous blood
77
427
1.90
6.05
11.6
8.5
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
89
519
1.82
5.97
2.5
1.8
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
10
16
6.32
5.97
2.3
1.4
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
10
16
6.32
5.97
2.3
1.4
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
10
16
6.32
5.97
2.3
1.4
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
10
16
6.32
5.97
2.3
1.4
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
280
2163
1.48
5.93
3.2
2.9
estimate
0.0
0.0
0.00
67
345
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
16
40
4.07
5.92
2.2
1.6
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
50
240
2.16
5.83
11.4
13.1
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
18
50
3.67
5.79
1.4
2.0
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
82
471
1.84
5.78
3.8
2.7
%
1.7
1.7
0.07
75
426
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
78
445
1.84
5.62
3.4
2.4
u/l
31.2
143.3
0.55
64
389
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
20
62
3.29
5.48
1.5
1.7
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
621
5677
1.68
5.47
20.7
10.1
—
—
—
0
0
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
8
5
16.16
5.42
1.0
1.0
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
24
85
2.89
5.29
1.3
1.3
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
25
93
2.75
5.05
1.6
1.5
ug/g
276.4
310.2
0.26
15
54
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
86
522
1.74
5.04
5.9
2.6
umol/l
11.9
10.0
0.19
77
463
(3002032) Base excess in Venous blood by calculation
80
476
1.77
5.03
5.2
3.4
mmol/l
1.6
1.9
0.39
65
385
(3013512) EKG study
173
1250
1.51
4.95
4.3
3.6
—
—
—
0
0
(3021447) Carbon dioxide [Partial pressure] in Venous blood
80
479
1.75
4.92
5.2
3.4
kpa
5.8
6.0
0.70
80
464
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
17
51
3.39
4.91
1.1
1.2
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
24
89
2.76
4.89
1.3
1.7
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
61
340
1.87
4.74
3.1
2.6
e9/l
61.3
68.6
1.01
45
262
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
352
2924
1.40
4.69
4.3
3.3
ug/l
2.4
1.7
0.61
311
2650
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
195
1460
1.46
4.64
3.4
2.6
u/l
54.0
58.7
1.40
181
1371
(3017181) Myelocytes/100 leukocytes in Blood
68
395
1.80
4.64
3.9
4.6
%
2.4
0.7
1.98
28
97
(3000330) Specific gravity of Urine by Test strip
36
167
2.22
4.60
4.4
3.1
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
62
357
1.81
4.36
3.2
4.5
%
1.5
0.4
1.14
22
74
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
50
270
1.92
4.29
2.0
1.6
—
—
—
0
0
(44806118)
16
51
3.19
4.23
2.2
1.9
—
—
—
0
0
(44790049)
16
51
3.19
4.23
2.3
1.9
—
—
—
0
0
(44790048)
16
51
3.19
4.23
2.3
1.9
—
—
—
0
0
(44790047)
16
51
3.19
4.23
2.2
1.9
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
11
27
4.12
4.17
1.3
2.1
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
28
122
2.35
4.15
1.4
1.4
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
220
1717
1.41
4.10
3.3
3.0
—
—
—
0
0
(3030981) Hyaline casts [#/volume] in Urine by Automated count
43
224
1.98
4.10
3.8
2.4
e6/l
0.1
0.2
0.91
43
218
(3042936) Bacteria identified in Isolate by Culture
105
708
1.57
4.09
2.1
2.3
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
24
99
2.47
4.01
4.5
3.6
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
13
38
3.47
3.91
5.8
3.1
—
—
—
0
0
(3000492) Spirometry study
96
641
1.57
3.90
1.9
1.4
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
16
54
3.01
3.87
1.3
1.6
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
21
85
2.51
3.66
1.5
1.6
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
17
62
2.78
3.61
1.5
1.5
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
7
9
7.84
3.56
1.0
2.2
—
—
—
0
0
(3001556) Androgen free Index in Serum or Plasma
7
9
7.84
3.56
1.3
1.2
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
60
366
1.70
3.50
2.6
2.2
ml/min/173m2
68.3
69.4
0.05
22
139
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
12
36
3.37
3.49
2.3
1.3
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
12
36
3.37
3.49
2.3
1.3
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
12
36
3.37
3.49
2.3
1.3
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
62
382
1.68
3.48
3.9
4.7
%
0.5
0.1
1.83
26
90
(3022313) Gas panel - Capillary blood
44
245
1.85
3.48
3.2
3.1
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
15
52
2.92
3.48
1.4
1.2
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
9
18
5.05
3.38
1.4
13.2
—
—
—
0
0
(40768441) Liver Pathology biopsy report
10
27
3.74
3.36
1.1
1.5
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
152
1152
1.40
3.29
5.3
4.9
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
502
5440
0.75
3.18
4.1
4.0
mmol/l
1.2
1.3
1.94
469
5109
(1616796) Gas panel - Central venous blood
24
111
2.20
3.16
4.3
3.6
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
52
315
1.70
3.13
3.9
3.1
mmol/l
1.3
1.7
0.36
39
223
(3006184) Hemoglobin [Mass/volume] in Capillary blood
21
92
2.32
3.13
3.1
2.4
g/l
130.9
137.7
0.38
13
67
(3007930) Methemoglobin/Hemoglobin.total in Blood
35
188
1.91
3.11
6.2
6.7
%
1.7
0.9
0.50
35
177
(3022145) Colonoscopy Study observation
74
491
1.57
3.11
1.5
1.4
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
514
5545
0.74
3.09
4.4
4.4
mmol/l
2.8
2.8
0.09
485
5203
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
31
160
1.98
3.09
2.9
1.7
—
—
—
0
0
(3008037) Lactate [Moles/volume] in Venous blood
22
99
2.26
3.09
4.4
2.9
mmol/l
1.4
1.7
1.19
22
93
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
25
119
2.14
3.07
1.4
1.6
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
17
68
2.54
3.06
1.5
1.5
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
79
536
1.53
3.01
10.9
8.8
mmol/l
0.8
1.1
0.49
64
417
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
131
982
1.41
3.01
2.6
2.1
mg/l
3.1
2.8
0.52
114
825
(4034850)
5
176
0.28
3.00
26.8
11.2
—
—
—
0
0
(3027273) Bicarbonate [Moles/volume] in Venous blood
40
230
1.78
2.89
4.7
3.0
mmol/l
23.9
25.2
1.59
40
221
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
22
102
2.19
2.89
1.4
1.3
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
22
102
2.19
2.89
1.4
1.3
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
57
362
1.62
2.88
4.0
4.8
%
0.1
0.0
0.39
23
78
(3049717) Cytology report of Urine Cyto stain
27
137
2.01
2.83
3.0
1.7
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
84
587
1.49
2.80
1.8
1.8
—
—
—
0
0
(3004119) Hemoglobin [Mass/volume] in Venous blood
52
326
1.64
2.77
3.6
2.7
g/l
125.4
136.9
2.22
52
318
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
5
6
8.38
2.75
1.0
3.0
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
17
72
2.39
2.74
1.1
1.6
—
—
—
0
0
(3009343) pH of Capillary blood
52
328
1.63
2.71
4.0
3.1
ph
7.4
7.4
—
7
37
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
43
258
1.71
2.70
1.4
1.4
—
—
—
0
0
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
78
541
1.50
2.70
10.9
8.7
kpa
5.2
5.1
0.05
73
514
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
212
1740
1.31
2.70
4.7
3.1
u/l
36.6
38.2
0.15
204
1647
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
13
49
2.68
2.63
1.2
1.1
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
156
1231
1.34
2.60
3.2
3.2
ng/l
1317.1
1495.0
0.25
134
1028
(3021901) Oxygen saturation in Capillary blood
19
87
2.22
2.59
5.0
2.4
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
11
38
2.92
2.59
3.5
2.4
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
510
5470
0.77
2.59
4.1
4.0
mmol/l
4.6
4.6
0.10
479
5154
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
9
25
3.63
2.58
1.2
1.7
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
12
44
2.76
2.55
2.1
2.1
—
—
—
0
0
(3008402) Methanol [Moles/volume] in Serum or Plasma
5
7
7.18
2.55
1.0
1.3
mmol/l
—
—
—
0
0
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
5
7
7.18
2.55
1.0
1.1
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
10
33
3.06
2.53
1.3
1.1
—
—
—
0
0
(3044889) 12 lead EKG panel
395
3529
1.26
2.50
3.6
3.5
—
—
—
0
0
(3002173) Hemoglobin [Mass/volume] in Arterial blood
65
442
1.52
2.48
12.4
9.9
g/l
119.3
128.6
2.74
65
424
(3024354) Oxygen [Partial pressure] in Venous blood
60
401
1.54
2.48
4.8
2.7
kpa
5.2
4.7
1.06
60
386
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
7
16
4.41
2.48
8.7
1.9
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
15
63
2.41
2.47
1.1
1.1
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
8
21
3.84
2.47
1.3
1.8
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
8
21
3.84
2.47
1.3
1.8
—
—
—
0
0
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
33
189
1.78
2.45
6.5
6.7
%
1.7
1.7
0.01
33
177
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
12
46
2.64
2.37
1.2
1.2
%
11.8
26.9
—
5
36
(3036481) Cortisol [Moles/volume] in Serum or Plasma
62
424
1.51
2.32
2.5
1.8
nmol/l
367.9
363.2
0.08
56
390
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
224
1885
1.27
2.30
4.0
3.5
ng/l
54.2
52.5
0.03
168
1242
(3048929) Epstein Barr virus Ab [Presence] in Serum
39
240
1.66
2.27
1.2
1.2
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
652
6256
1.45
2.23
32.0
15.8
e9/l
232.8
238.1
1.60
637
6088
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
26
143
1.85
2.21
2.4
1.5
—
—
—
0
0
(4268621)
13
54
2.43
2.21
3.1
2.6
—
—
—
0
0
(3028772) Osteocalcin [Mass/volume] in Serum or Plasma
12
48
2.53
2.19
2.2
3.0
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
392
3533
1.24
2.17
4.0
3.7
mm/h
11.9
8.9
3.11
365
3280
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
9
30
3.02
2.15
1.3
1.1
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
9
30
3.02
2.15
1.3
1.1
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
9
30
3.02
2.15
1.3
1.1
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
9
30
3.02
2.15
1.3
1.1
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
9
30
3.02
2.15
1.3
1.1
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
9
30
3.02
2.15
1.3
1.1
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
27
152
1.81
2.15
1.1
1.2
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
15
68
2.23
2.12
1.5
1.2
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
12
49
2.47
2.11
3.2
3.9
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
493
5268
0.80
2.10
3.7
3.6
mmol/l
1.5
1.4
0.99
458
4941
(3035941) MCH [Entitic mass]
652
6268
1.43
2.08
31.8
15.7
pg
30.2
30.4
2.18
647
6171
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
196
1643
1.27
2.06
2.6
2.4
ug/l
0.7
0.7
0.41
123
932
(3033705) Calcium.ionized [Moles/volume] in Venous blood
13
56
2.35
2.05
3.1
2.4
—
—
—
0
0
(3026361) Erythrocytes [#/volume] in Blood
652
6270
1.42
2.05
31.9
15.8
e12/l
4.7
4.8
9.37
635
6086
(3051611) Lipemic interference index of Serum or Plasma
11
44
2.52
2.02
12.8
3.6
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
19
97
1.98
2.02
1.5
1.2
—
—
—
0
0
(3010813) Leukocytes [#/volume] in Blood
652
6274
1.42
2.00
31.9
15.9
e9/l
6.4
6.7
3.10
636
6095
(3025941) Bacteria identified in Stool by Culture
42
273
1.57
2.00
1.2
1.2
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
76
559
1.40
1.98
1.2
1.2
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
5
11
4.57
1.94
1.8
3.5
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
8
27
2.98
1.94
2.6
2.0
—
—
—
0
0
(3000012) Reticulocyte production index
6
16
3.77
1.94
1.3
1.6
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
12
52
2.33
1.88
2.0
3.4
—
—
—
0
0
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
36
229
1.60
1.88
5.8
3.3
%
53.9
51.6
0.21
36
224
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
20
107
1.89
1.88
1.1
1.1
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
9
34
2.67
1.87
1.2
1.6
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
28
167
1.70
1.86
1.4
1.2
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
5
12
4.19
1.82
1.0
1.0
—
—
—
0
0
(3018301) Testosterone Free [Moles/volume] in Serum or Plasma
22
123
1.81
1.82
1.3
1.3
pmol/l
64.9
71.3
0.11
16
30
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
11
47
2.36
1.78
1.1
1.0
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
11
47
2.36
1.78
1.3
1.1
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
11
47
2.36
1.78
1.1
1.0
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
9
36
2.52
1.74
15.0
3.7
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
34
513
0.65
1.72
2.2
3.4
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
7
24
2.93
1.72
1.1
1.1
—
—
—
0
0
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
5
13
3.86
1.71
3.6
1.8
—
—
—
0
0
(40757373) Influenza virus identified in Isolate
5
13
3.86
1.71
1.0
2.2
—
—
—
0
0
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
30
187
1.63
1.71
2.2
3.2
pmol/l
5.1
4.8
0.50
25
170
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
11
48
2.31
1.71
1.8
1.2
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
11
48
2.31
1.71
1.8
1.2
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
11
48
2.31
1.71
1.8
1.2
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
11
48
2.31
1.71
1.8
1.2
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
34
511
0.65
1.70
1.9
2.9
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
25
149
1.70
1.69
1.1
1.2
u/ml
274.9
268.7
0.04
17
88
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
11
49
2.26
1.64
1.8
1.2
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
11
49
2.26
1.64
1.8
1.2
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
34
506
0.66
1.63
1.9
3.4
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
17
91
1.89
1.61
4.0
2.6
%
16.8
17.2
0.12
12
52
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
15
77
1.97
1.60
2.3
1.3
u/ml
3.8
8.4
—
6
26
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
454
4841
0.83
1.59
5.7
5.2
mmol/mol
39.8
39.6
0.14
417
4558
(3019309) Folate [Moles/volume] in Red Blood Cells
98
778
1.30
1.59
1.9
1.7
nmol/l
1074.1
1164.3
0.50
72
607
(3034860) Kappa light chains.free [Mass/volume] in Serum
18
99
1.84
1.58
1.8
1.3
mg/l
56.0
47.5
0.24
13
77
(3016228) CD19 cells/100 cells in Blood
6
20
3.02
1.58
3.2
1.8
%
4.8
7.1
—
6
20
(21494814) CD8 cells/100 lymphocytes in Specimen
6
20
3.02
1.58
3.2
1.8
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
20
114
1.78
1.58
1.4
1.2
—
—
—
0
0
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
18
100
1.82
1.54
1.9
1.3
mg/l
44.3
36.3
0.24
13
79
(3016018) Differential panel - Cerebral spinal fluid
11
51
2.17
1.51
1.3
1.3
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
34
497
0.67
1.50
1.9
3.2
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
11
52
2.13
1.45
1.1
1.0
—
—
—
0
0
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
14
73
1.94
1.44
2.4
1.3
u/ml
6.3
7.0
—
8
40
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
476
5034
0.84
1.42
4.2
3.9
mmol/l
6.0
6.0
0.16
433
4631
(3035637) Corticotropin [Mass/volume] in Plasma
9
40
2.27
1.40
1.8
1.5
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
33
477
0.68
1.39
1.9
3.5
—
—
—
0
0
(3012501) Base excess in Blood by calculation
18
104
1.75
1.38
4.8
4.4
mmol/l
3.5
2.3
0.59
13
56
(3011397) Hemoglobin [Presence] in Urine by Test strip
114
942
1.25
1.35
2.7
3.1
—
—
—
0
0
(3027923) C peptide [Moles/volume] in Serum or Plasma
0
37
0.00
1.34
0.0
1.2
—
1.2
—
0
26
(3015235) Bicarbonate [Moles/volume] in Capillary blood
21
128
1.66
1.34
6.0
2.3
mmol/l
24.9
24.4
0.20
21
112
(3045683) HLA typing for celiac disease panel - Blood or Tissue
0
39
0.00
1.34
0.0
1.1
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
16
90
1.80
1.34
1.1
1.8
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
21
329
0.63
1.30
2.9
5.3
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
8
34
2.37
1.29
1.6
1.4
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
20
315
0.62
1.27
1.3
1.7
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
32
220
1.48
1.25
1.8
1.3
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
553
5292
1.19
1.22
24.0
11.7
%
40.8
42.6
4.46
439
4149
(3020650) Glucose [Presence] in Urine
5
19
2.64
1.22
1.2
1.4
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
23
148
1.57
1.21
2.7
3.1
g/l
0.2
0.3
0.57
11
74
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
68
538
1.29
1.17
3.8
4.3
%
28.3
29.6
0.42
52
383
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
198
1755
1.18
1.15
1.9
1.8
pmol/l
90.8
94.0
0.44
113
987
(3015076) Soybean IgE Ab [Units/volume] in Serum
0
35
0.00
1.15
0.0
1.1
—
13.2
—
0
6
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
0
36
0.00
1.14
0.0
1.2
—
0.4
—
0
22
(3018572) Chloride [Moles/volume] in Blood
17
103
1.67
1.13
9.5
10.2
mmol/l
104.3
105.8
0.82
17
94
(3039000) Anion gap in Blood
17
103
1.67
1.13
9.5
10.2
mmol/l
11.3
11.9
0.59
17
94
(3010503) CD19 cells [#/volume] in Blood
7
30
2.35
1.12
4.4
2.4
e9/l
0.1
0.2
—
7
30
(3024928) Oxygen saturation in Venous blood
20
127
1.59
1.12
2.9
2.5
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
24
160
1.52
1.10
2.2
3.7
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
7
31
2.27
1.10
1.9
2.5
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
22
144
1.54
1.10
9.8
3.2
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
46
600
0.75
1.09
1.2
1.2
u/ml
3.3
8.1
0.99
12
252
(3029937) Albumin [Presence] in Urine by Test strip
132
1135
1.20
1.09
3.4
3.2
estimate
0.0
0.0
0.25
69
353
(1761868) Lipid panel - Serum or Plasma
205
2281
0.86
1.07
2.9
2.5
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
25
170
1.49
1.06
1.1
1.1
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
99
830
1.22
1.06
1.8
2.2
—
—
—
0
0
(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum
7
33
2.13
1.05
1.3
1.0
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
28
392
0.70
1.04
2.0
3.7
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
9
46
1.97
1.04
1.1
1.2
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
9
46
1.97
1.04
1.0
1.1
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
37
273
1.37
1.03
7.1
4.4
ng/l
125.7
95.6
1.01
30
244
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
27
188
1.45
1.03
2.5
2.4
ug/l
230.5
592.7
0.88
27
183
(44786774) Adalimumab [Mass/volume] in Serum or Plasma
0
30
0.00
0.97
0.0
1.7
—
8.6
—
0
23
(3023410) Appearance of Cerebral spinal fluid
9
50
1.81
0.97
1.3
1.5
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
253
2315
1.14
0.95
3.5
3.2
%
21.1
23.8
1.58
101
883
(3040151) Glucose [Moles/volume] in Capillary blood
9
52
1.74
0.92
2.8
5.0
mmol/l
6.4
7.4
—
9
47
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
56
691
0.79
0.90
1.2
1.2
iu/ml
15.0
23.6
1.65
17
201
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
8
42
1.91
0.88
1.6
1.4
g/l
1.2
1.0
—
8
42
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
10
56
1.80
0.88
2.4
2.2
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
10
56
1.80
0.88
1.2
1.1
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
89
755
1.20
0.87
1.8
2.2
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
12
72
1.68
0.85
6.4
3.2
—
—
—
0
0
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
12
73
1.65
0.82
1.2
1.1
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
22
155
1.43
0.82
1.4
1.1
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
91
1057
0.84
0.81
1.3
1.2
u/ml
4.7
1.6
0.49
23
313
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
13
81
1.62
0.81
1.2
1.1
—
—
—
0
0
(3025443) Phadiatop IgE Ab [Units/volume] in Serum
0
24
0.00
0.79
0.0
1.1
—
6.5
—
0
7
(3001122) Ferritin [Mass/volume] in Serum or Plasma
195
1776
1.13
0.78
3.7
2.5
ug/l
207.6
173.4
1.13
178
1643
(3028707) Methadone [Presence] in Urine by Screen method
14
208
0.67
0.75
2.6
5.4
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
5
24
2.09
0.74
1.0
1.5
—
—
—
0
0
(4094501)
8
136
0.58
0.73
1.0
1.1
—
—
—
0
0
(40768446) Kidney Pathology biopsy report
5
25
2.01
0.73
1.4
1.6
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
7
39
1.80
0.72
1.6
1.1
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
108
950
1.16
0.71
4.1
3.5
ng/l
504.3
857.7
0.78
84
712
(3016650) Hepatitis A virus Ab [Presence] in Serum
18
126
1.44
0.71
1.1
1.1
—
—
—
0
0
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
5
26
1.93
0.70
2.0
2.1
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
18
251
0.71
0.70
1.1
1.3
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
22
161
1.38
0.69
1.7
1.8
—
—
—
0
0
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
25
329
0.75
0.69
2.6
2.4
au/ml
31.8
16.0
—
5
27
(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight
7
42
1.67
0.68
1.0
1.4
—
—
—
0
0
(4010399)
42
339
1.25
0.68
1.1
1.5
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
15
102
1.48
0.68
1.2
1.2
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
21
153
1.38
0.67
1.2
1.1
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
5
28
1.79
0.66
3.0
1.1
—
—
—
0
0
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
18
128
1.42
0.66
1.1
1.2
mg/l
568.0
541.1
0.18
18
120
(3041806) Other cells [#/volume] in Blood by Manual count
5
29
1.73
0.64
1.2
1.3
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
21
155
1.37
0.63
1.2
1.1
—
—
—
0
0
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
15
104
1.45
0.63
1.2
1.2
mmol/l
3.7
3.8
0.28
15
95
(3011648) Oxygen content in Venous blood
8
49
1.64
0.62
1.5
2.0
%
10.6
11.5
—
8
49
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
5
30
1.67
0.61
1.8
1.5
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
0
20
0.00
0.60
0.0
1.1
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
106
946
1.14
0.59
1.5
1.5
nmol/l
18.4
19.2
0.25
94
812
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
0
23
0.00
0.58
0.0
1.1
—
—
—
0
0
(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection
6
36
1.67
0.56
1.7
1.7
—
2294428.6
—
0
7
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
9
60
1.51
0.54
1.1
1.0
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
6
38
1.58
0.54
1.7
1.1
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
95
1061
0.88
0.54
1.8
2.0
%
1.5
1.5
0.01
90
958
(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma
6
39
1.54
0.53
1.7
1.4
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
6
39
1.54
0.53
1.7
1.1
—
—
—
0
0
(40765089) Chromosome analysis panel - Blood by G-banded
6
40
1.50
0.51
1.0
1.0
—
—
—
0
0
(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma
9
64
1.41
0.51
1.9
2.0
nmol/l
20.9
21.5
—
9
59
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
18
135
1.34
0.51
1.2
1.6
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
154
1666
0.90
0.51
3.1
3.8
mmol/l
9.3
9.1
0.15
123
1423
(3014148) Varicella zoster virus Ab [Titer] in Serum
11
75
1.47
0.51
1.0
1.1
—
—
—
0
0
(4027681)
6
41
1.47
0.50
1.0
1.4
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
10
67
1.50
0.50
1.8
3.1
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
7
48
1.46
0.47
1.0
1.3
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
63
715
0.87
0.47
1.7
1.7
—
—
—
0
0
(3024474) Albumin [Mass/volume] in Cerebral spinal fluid
7
49
1.43
0.46
1.0
1.1
mg/l
272.9
284.2
—
7
40
(3001019) Free T4 and TSH panel - Serum or Plasma
17
220
0.77
0.45
1.2
1.4
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
71
631
1.14
0.45
1.2
1.3
titre
436.4
322.2
0.39
11
108
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
7
51
1.38
0.44
1.1
1.0
—
—
—
0
0
(3007368) IgG [Mass/volume] in Cerebral spinal fluid
7
51
1.38
0.44
1.0
1.2
mg/l
55.7
43.9
—
7
40
(40768443) Skin Pathology biopsy report
20
158
1.27
0.42
1.0
1.2
—
—
—
0
0
(40761535) Cells panel - Urine sediment
31
369
0.83
0.41
2.7
2.9
—
—
—
0
0
(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum
0
15
0.00
0.41
0.0
1.2
—
—
—
0
0
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
0
15
0.00
0.41
0.0
1.0
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
8
59
1.36
0.41
1.0
1.0
—
—
—
0
0
(3042517) Benzodiazepines panel - Urine
0
17
0.00
0.40
0.0
2.9
—
—
—
0
0
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
0
17
0.00
0.40
0.0
1.0
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
5
34
1.47
0.40
1.0
1.0
miu/ml
1438.8
1600.9
—
5
34
(3014051) Protein [Presence] in Urine by Test strip
8
60
1.34
0.40
3.4
1.8
—
—
—
0
0
(3032567) Hepatitis B virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
0
18
0.00
0.40
0.0
1.5
—
—
—
0
0
(21494434) Karyotype in Bone marrow
5
35
1.43
0.39
1.0
1.3
—
—
—
0
0
(40757494) Bilirubin.total [Moles/volume] in Blood
5
35
1.43
0.39
1.4
1.5
—
22.9
—
0
5
(3037556) Urate [Mass/volume] in Serum or Plasma
0
19
0.00
0.39
0.0
1.2
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
9
66
1.37
0.38
1.1
1.1
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
353
3411
1.07
0.38
3.2
2.8
pmol/l
14.9
14.9
0.03
316
3093
(3038177) Helicobacter pylori Ab [Presence] in Serum
12
89
1.35
0.38
1.3
1.2
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
78
858
0.90
0.37
1.2
1.3
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
30
255
1.18
0.35
1.3
1.2
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
6
45
1.34
0.34
1.0
1.3
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
23
191
1.21
0.33
2.9
2.1
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
6
90
0.66
0.33
1.3
1.6
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
56
622
0.89
0.33
3.7
3.1
ug/g
232.8
159.1
0.75
51
528
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
7
53
1.32
0.31
1.1
1.0
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
27
232
1.17
0.29
3.2
2.8
—
—
—
0
0
(3019060) Gas panel - Arterial blood
37
327
1.14
0.28
6.4
5.9
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
18
149
1.21
0.28
2.1
1.5
—
—
—
0
0
(3022621) pH of Urine by Test strip
27
233
1.16
0.28
2.6
2.5
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
23
196
1.18
0.27
3.3
2.8
—
—
—
0
0
(3024980) IgG subclass 4 [Mass/volume] in Serum
12
95
1.27
0.26
2.7
2.0
g/l
0.7
1.1
0.80
12
74
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
151
1437
1.06
0.26
2.5
2.2
u/l
180.4
351.5
1.39
146
1355
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
16
132
1.22
0.26
2.0
2.0
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
97
1033
0.93
0.25
3.1
3.4
kg/l
1.0
1.0
0.06
15
127
(3045424) Erythrocytes [Presence] in Urine
9
73
1.24
0.25
1.1
1.2
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
18
152
1.19
0.24
1.1
1.3
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
5
39
1.28
0.23
1.6
1.3
—
—
—
0
0
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
28
248
1.13
0.22
2.2
2.2
u/l
41.4
39.4
0.15
23
224
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
412
4043
1.04
0.22
3.7
3.1
u/l
62.5
49.3
1.44
395
3836
(3004616) Nuclear Ab [Presence] in Serum
5
42
1.19
0.21
1.0
1.1
—
—
—
0
0
(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(3008116) Ketones [Moles/volume] in Urine by Test strip
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(3024869) Neuronal Ab [Presence] in Serum
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
(3007463) Buprenorphine [Presence] in Urine
0
12
0.00
0.21
0.0
6.5
—
—
—
0
0
(3027231) Wheat IgE Ab [Units/volume] in Serum
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
15
126
1.19
0.21
1.1
1.1
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
64
596
1.08
0.21
1.7
1.5
—
—
—
0
0
(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright
0
13
0.00
0.21
0.0
1.2
—
173.7
—
0
7
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
14
166
0.84
0.20
1.9
1.8
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
10
80
1.25
0.20
1.0
1.2
—
—
—
0
0
(3033923) Metanephrine [Moles/time] in 24 hour Urine
0
14
0.00
0.20
0.0
1.1
—
0.8
—
0
9
(1002224) Polysomnography panel
30
333
0.90
0.19
1.1
1.1
—
—
—
0
0
(4062490)
6
51
1.18
0.19
1.2
1.4
—
—
—
0
0
(3024139) IgG subclass 3 [Mass/volume] in Serum
6
51
1.18
0.19
1.2
1.3
g/l
0.3
0.4
—
6
33
(3028192) IgG subclass 2 [Mass/volume] in Serum
6
51
1.18
0.19
1.2
1.3
g/l
2.8
3.1
—
6
33
(3027135) IgG subclass 1 [Mass/volume] in Serum
6
51
1.18
0.19
1.2
1.3
g/l
7.8
6.8
—
6
33
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
17
147
1.16
0.18
1.9
2.4
mg/l
11.5
10.3
0.23
17
138
(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma
7
59
1.19
0.18
1.1
1.0
mg/l
242.6
266.0
—
7
53
(36660697) Celiac disease serology panel - Serum
34
371
0.91
0.17
1.2
1.2
—
—
—
0
0
(3020891) Body temperature
19
214
0.88
0.16
3.3
4.6
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
10
83
1.21
0.15
1.0
1.1
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
16
182
0.88
0.15
1.3
1.4
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
9
79
1.14
0.15
1.0
1.2
—
—
—
0
0
(4306422)
10
84
1.19
0.14
1.2
1.2
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
103
1069
0.96
0.13
1.5
1.4
—
—
—
0
0
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
19
211
0.90
0.13
1.4
1.7
—
230.0
—
0
6
(3021788) Differential panel - Synovial fluid
10
85
1.18
0.12
1.1
1.4
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
444
4397
1.03
0.11
3.8
3.4
mu/l
1.8
2.2
0.64
400
4024
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
15
166
0.90
0.10
1.1
1.3
miu/ml
215.3
171.6
—
8
69
(3012516) Albumin [Mass/volume] in Urine
136
1392
0.97
0.09
3.2
3.5
mg/l
49.6
249.2
1.57
90
948
(3003740) Influenza virus B Ag [Presence] in Specimen
14
126
1.11
0.09
1.1
1.1
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
145
1481
0.97
0.08
4.0
4.3
mg/mmol
10.3
10.7
0.04
92
1017
(3011985) Renin [Units/volume] in Plasma
6
57
1.05
0.08
1.3
1.5
mu/l
46.5
64.4
—
6
46
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
6
58
1.03
0.08
1.2
1.4
—
—
—
0
0
(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma
5
63
0.79
0.08
1.2
1.3
—
0.4
—
0
9
(4198724)
5
64
0.78
0.08
1.4
5.3
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
14
154
0.91
0.08
1.9
2.4
ug/min
67.9
117.9
—
9
90
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
14
128
1.10
0.06
1.6
1.3
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
11
99
1.11
0.06
1.2
1.1
—
—
—
0
0
(3008898) HLA-B27 [Presence]
19
203
0.93
0.06
1.1
1.1
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
45
465
0.97
0.05
1.5
1.4
—
—
—
0
0
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
12
130
0.92
0.04
5.1
1.4
g/l
1.3
1.2
0.49
12
124
(3007164) IgA [Mass/volume] in Serum or Plasma
98
966
1.02
0.03
1.6
1.4
g/l
2.4
2.7
0.63
68
650
(3022217) INR in Platelet poor plasma by Coagulation assay
60
612
0.98
0.03
32.7
24.3
inr
1.3
1.3
—
10
83
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
46
471
0.98
0.03
1.4
1.4
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
24
231
1.04
0.03
1.0
1.1
—
—
—
0
0
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
12
128
0.94
0.02
5.1
1.3
g/l
0.3
0.2
0.39
12
122
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
131
1320
0.99
0.01
1.8
1.7
mmol/l
1.6
1.5
0.16
107
1126
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
93
921
1.01
0.01
1.7
1.7
pmol/l
423.6
52692720.7
1.46
75
780
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
75
757
0.99
0.01
1.4
1.4
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
15
144
1.04
0.00
1.0
1.1
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
400
4007
1.00
0.00
2.9
3.0
—
—
—
0
0
(3009445) Proteinase 3 Ab [Units/volume] in Serum
24
246
0.97
0.00
1.2
1.7
—
9.5
—
0
13
(3008152) Bicarbonate [Moles/volume] in Arterial blood
30
306
0.98
0.00
9.1
8.4
mmol/l
24.2
24.2
0.01
30
285
(3017732) Neutrophils [#/volume] in Blood
31
316
0.98
0.00
1.7
3.0
e9/l
4.7
4.1
0.53
23
257
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
14
136
1.03
0.00
1.1
1.3
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
23
235
0.98
0.00
1.5
1.6
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
57
575
0.99
0.00
9.0
6.6
—
—
—
0
0
(3032057) Clostridioides difficile [Presence] in Stool
0
8
0.00
0.00
0.0
2.3
—
—
—
0
0
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3016273) Islet cell 512 Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
9
96
0.94
0.00
1.0
1.3
u/l
45.4
16.2
—
9
85
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3051101) Glucose [Moles/volume] in Cord blood
0
8
0.00
0.00
0.0
6.8
—
—
—
0
0
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
172
1720
1.00
0.00
2.6
2.3
nmol/l
71.6
71.4
0.02
155
1567
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
0
9
0.00
0.00
0.0
1.0
—
2.1
—
0
9
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3036180) Methadone [Presence] in Urine
0
7
0.00
0.00
0.0
2.7
—
—
—
0
0
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3014891) Appearance of Pleural fluid
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
6
62
0.97
0.00
1.7
1.2
—
—
—
0
0
(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3002067) Lambda light chains [Mass/time] in 24 hour Urine
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(36305790) Ustekinumab [Mass/volume] in Serum or Plasma by Immunoassay
0
6
0.00
0.00
0.0
1.5
—
3.2
—
0
6
(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay
0
9
0.00
0.00
0.0
1.3
—
85.6
—
0
9
(3000034) Microalbumin [Mass/volume] in Urine
5
58
0.86
0.00
3.8
2.9
mg/l
94.4
17.8
—
5
50
(3013762) Body weight Measured
0
9
0.00
0.00
0.0
1.4
—
—
—
0
0
(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(40760435) Tropomyosin IgE Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3027570) Oxalate [Moles/time] in 24 hour Urine
0
5
0.00
0.00
0.0
1.0
—
258.8
—
0
5
(3019768) Coxiella burnetii Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3004446) Plasmodium sp identified in Blood by Light microscopy
0
9
0.00
0.00
0.0
2.1
—
—
—
0
0
(3000285) Sodium [Moles/volume] in Blood
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3010144) Erythrocytes [#/volume] in Synovial fluid
5
51
0.98
0.00
1.2
1.2
e6/l
9039.0
66433.2
—
5
40
(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood
8
81
0.99
0.00
1.5
1.2
—
—
—
0
0
(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3025315) Body weight
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3038864) risperiDONE [Moles/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.4
—
15.0
—
0
9
(3011335) Digoxin [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
3.8
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
5
51
0.98
0.00
2.0
6.3
—
—
—
0
0
(3005011) Chlamydia sp Ab [Titer] in Serum
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
5
59
0.85
0.00
1.4
2.0
—
—
—
0
0
(3044416) Complement C4 [Mass/volume] in Pleural fluid
0
5
0.00
0.00
0.0
1.0
—
0.0
—
0
5
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
7
79
0.88
0.00
1.0
1.0
—
—
—
0
0

Mortality – FinRegistry

↥

This endpoint is excluded (different definition than used in FinnGen).

Relationships between endpoints

↥

Index endpoint: C3_TESTIS_EXALLC – Malignant neoplasm of testis, excluding all cancers (controls excluding all cancers)

GWS hits: 3

This endpoint is excluded (different definition than used in FinnGen).